EP0587765A4 - Induktion der immunantwort gegen das tetanustoxin durch verarbeitung von mycobakterien, die das tetanustoxin oder fragmente davon exprimieren. - Google Patents

Induktion der immunantwort gegen das tetanustoxin durch verarbeitung von mycobakterien, die das tetanustoxin oder fragmente davon exprimieren.

Info

Publication number
EP0587765A4
EP0587765A4 EP9292913474A EP92913474A EP0587765A4 EP 0587765 A4 EP0587765 A4 EP 0587765A4 EP 9292913474 A EP9292913474 A EP 9292913474A EP 92913474 A EP92913474 A EP 92913474A EP 0587765 A4 EP0587765 A4 EP 0587765A4
Authority
EP
European Patent Office
Prior art keywords
tetanus toxin
fragments
induction
administration
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP9292913474A
Other languages
English (en)
French (fr)
Other versions
EP0587765A1 (de
Inventor
Charles K Stover
Cruz Vidal Dela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of EP0587765A1 publication Critical patent/EP0587765A1/de
Publication of EP0587765A4 publication Critical patent/EP0587765A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP9292913474A 1991-06-06 1992-06-01 Induktion der immunantwort gegen das tetanustoxin durch verarbeitung von mycobakterien, die das tetanustoxin oder fragmente davon exprimieren. Withdrawn EP0587765A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71108491A 1991-06-06 1991-06-06
US711084 1991-06-06

Publications (2)

Publication Number Publication Date
EP0587765A1 EP0587765A1 (de) 1994-03-23
EP0587765A4 true EP0587765A4 (de) 1994-11-02

Family

ID=24856707

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9292913474A Withdrawn EP0587765A4 (de) 1991-06-06 1992-06-01 Induktion der immunantwort gegen das tetanustoxin durch verarbeitung von mycobakterien, die das tetanustoxin oder fragmente davon exprimieren.

Country Status (4)

Country Link
EP (1) EP0587765A4 (de)
AU (1) AU2221992A (de)
CA (1) CA2110687A1 (de)
WO (1) WO1992021374A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566121B1 (en) 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
GB9808932D0 (en) * 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006626A1 (en) * 1987-03-02 1988-09-07 Whitehead Institute For Biomedical Research Recombinant mycobacterial vaccine
WO1990000594A2 (en) * 1988-07-07 1990-01-25 Whitehead Institute For Biomedical Research Recombinant mycobacterial expression vehicles and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69034100T2 (de) * 1989-06-19 2004-06-09 Whitehead Institute For Biomedical Research, Cambridge Verktorvermittelte genominsertion und expression von dna in bcg

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006626A1 (en) * 1987-03-02 1988-09-07 Whitehead Institute For Biomedical Research Recombinant mycobacterial vaccine
WO1990000594A2 (en) * 1988-07-07 1990-01-25 Whitehead Institute For Biomedical Research Recombinant mycobacterial expression vehicles and uses therefor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Annual meeting modern approaches to new vaccines8th 1990 *
See also references of WO9221374A1 *
VIDAL F. DE LA CRUZ ET AL.: "Humoral and cellular immune responses to recombinant Mycobacteria (BCG)", VACCINES 91. MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, 1991, pages 399 - 402 *

Also Published As

Publication number Publication date
WO1992021374A1 (en) 1992-12-10
EP0587765A1 (de) 1994-03-23
AU2221992A (en) 1993-01-08
CA2110687A1 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
TJ384B (en) Microfluidized compostion for induction of specific cytotoxic t-lymphocyte immune response and its using for disease treatment.
CA2138137A1 (en) Diphtheria toxin vaccines
EP0605442A4 (de) Rekombinante antikörper zur humanen therapie.
FI883393A (fi) Anordning foer behandling av saed.
AU1496288A (en) Recombinant ricin toxin fragments
EP0618803A4 (de) Polypeptide als inhibitoren gegen cholesterylester-transferase, antikörper gegen die synthetischen polypeptide und prophylaktische und therapeutische behandlungsweisen der atherosklerose.
EP0587775A4 (de) Induktion der ctl-antwort durch in mycobakterien exprimierte fremde antigene.
EP0555366A4 (en) Bacterial attenuation method and vaccine
EP0603187A4 (en) Human lactoferrin.
ZA927562B (en) Medicament.
EP0630410A4 (de) Verfahren zur herstellung von poly-beta-hydroxyalkanoat-copolymeren.
JPS57176916A (en) Novel thiolated polypeptide derived from tetanus toxin fragment, preparation and application
EP0596962A4 (en) Therapeutic compositions and methods.
HU9302642D0 (en) Gp 160-derivatives and vaccine containing them or gp-160 itself
EP0663599A4 (de) Magnetische fühler und magnetische detektor.
FR2673093B3 (fr) Percolateur pour expresso et capuccino.
EP0661061A3 (de) Impfstoff geeignet von ein Immunresponz hervorzurufen gegen N-Glycolysierte-Gangliosiden und ihre Anwendung in Antikrebsmittel.
EP0635058A4 (de) Protease impfstoff gegen dirofilaria immitis.
EP0590905A3 (de) Magnetischer Sensor.
DE69112755D1 (de) Steuergerät mit verringertem Schlupf des Endausschlags.
NZ226442A (en) Anti-coleopteran toxin and gene
GB8802612D0 (en) Beverage infusing device
EP0587765A4 (de) Induktion der immunantwort gegen das tetanustoxin durch verarbeitung von mycobakterien, die das tetanustoxin oder fragmente davon exprimieren.
EP0427768A4 (en) Polypeptide pertussis toxin vaccine
ZA928959B (en) Magnetic separation of materials.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940104

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

RHK1 Main classification (correction)

Ipc: C12N 15/74

A4 Supplementary search report drawn up and despatched

Effective date: 19940916

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19941231